Literature DB >> 1211859

Studies of catecholamines in amyloidosis.

O Penttilä, A Ahonen, E Klinge, E Alhava.   

Abstract

Amyloidosis was induced in 21 mice by daily injections of casein solution for four weeks. Thioflavine T staining showed that the induction of amyloidosis took place in all mice. The catecholamine (CA) content was estimated in the spleen, proximal colon and kidney. In spleen the noradrenaline (NA) content per wet weight of tissue in casein-induced amyloidosis was significantly (p less than 0.01) lower than in the controls but this reduction was not apparent because of the huge increase in the weight of amyloid spleens. In the proximal colon and kidney the NA content did not differ from the control values. By fluorescence histochemistry the adrenergic fibres appeared to be well maintained in the spleen, duodenum and proximal colon in casein-induced amyloidosis. The CA content of rectal mucosal biopsies from five patients suffering from amyloidosis was compared with that from seven control persons. There was no significant difference in NA content. The present results suggest that in amyloid disease detectable alterations in the CA content or such morphological changes in adrenergic nerve fibres, which can be detected by fluorescence histochemistry take place only in the most advanced disease, if at all.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1211859

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  2 in total

1.  The prevalence of colonic amyloidosis in baboons. A 22-year survey at a large primate facility.

Authors:  Carlos A Rubio; Edward J Dick; Gene B Hubbard
Journal:  In Vivo       Date:  2008 Nov-Dec       Impact factor: 2.155

2.  A single nucleotide polymorphism in dopamine beta hydroxylase (rs6271(C>T)) is over-represented in inflammatory bowel disease patients and reduces circulating enzyme.

Authors:  Eugene Gonzalez-Lopez; Yuka Kawasawa-Imamura; Lijun Zhang; Xuemei Huang; Walter A Koltun; Matthew D Coates; Kent E Vrana
Journal:  PLoS One       Date:  2019-02-28       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.